Clinical Trials Logo
  1. Home
  2. Urge Incontinence
  3. NCT05391425

The Effect of Solifenacin Used for Lower Urinary Tract Symptoms on Sexual Function

Urge Incontinence Clinical Trial

Official title:
The Effect of Solifenacin Used for Lower Urinary Tract Symptoms on Sexual Function in Premenopausal vs Postmenopausal Women: A Prospective Observational Study

Clinical Trial Summary

This study aims to determine whether Solifenacine used for lower urinary tract symptoms improves sexual function and if so does this improvement differs between premenopausal and postmenopausal women.

Clinical Trial Description

Solifenacin is an anticholinergic drug that is commonly used for lower urinary tract symptoms such as urgency, frequency and urge urinary incontinence. Solifenacin use and sexual function improvement is presented in some research, but the correlation between the improvement in sexual function and LUTS symptoms is yet not investigated. Also the effect on sexual function in premenopausal vs postmenopausal women are unknown. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05391425
Study type Observational
Source Istanbul University
Contact Inci Sema Tas, MD
Phone 00905359509232
Email incisematas@gmail.com
Status Recruiting
Phase
Start date June 3, 2021
Completion date June 3, 2024
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03556891 - Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence N/A
Active, not recruiting NCT04936464 - Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence N/A
Completed NCT04470765 - Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence N/A
Recruiting NCT05415865 - The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder Phase 3
Recruiting NCT05099419 - Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence Early Phase 1
Recruiting NCT05874375 - UCon Treatment of Overactive Bladder (OAB) in Males N/A
Active, not recruiting NCT05241379 - AURA-2: Augmenting Urinary Reflex Activity N/A
Completed NCT02657057 - Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB N/A
Withdrawn NCT00773552 - Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder Phase 4
Recruiting NCT04752709 - Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women N/A
Recruiting NCT03755089 - Oral vs Intravesical Analgesia for Office Bladder Botox Injections Phase 4
Terminated NCT03687164 - Group Medical Visits for Latina Women With Urgency Urinary Incontinence N/A
Withdrawn NCT03697954 - Direct Full-stage Implantation of Sacral Neuromodulation
Completed NCT00337558 - A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) Phase 4
Completed NCT03180372 - Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence N/A
Completed NCT05783219 - Lidocaine Patches Prior to Percutaneous Nerve Evaluation Phase 2
Active, not recruiting NCT05308979 - Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial Phase 4
Completed NCT03672461 - A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women N/A
Completed NCT01391780 - Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence N/A
Completed NCT03655054 - eCoin for OAB Feasibility Follow-on Study N/A